(Total Views: 519)
Posted On: 03/05/2021 11:50:27 AM
Post# of 148899
When Nader said on the KOIN interview, that CYDY is a 3 digit stock, he may have been referring to the share price after approvals for covid, HIV and breast cancer, and/or NASH etc. When he adds that this is a "conservative" estimate, he must have been including the other multiple diseases for leronlimab.
My point to make, my opinion, regardless of my above theory, if for example he knew our s/c trial data missed the PE, but the FDA was attempting to scrutinize the data in order to justify an EUA, then, this would have been extremely risky and stupid and negative "risking" his integrity and credibility, for Nader to have made the above statements.
Conclusion:
It's probable he does know that we did meet the PE with p value <0.05
Less Likely is that Nader has not seen the data & took big risk with big statements.
My point to make, my opinion, regardless of my above theory, if for example he knew our s/c trial data missed the PE, but the FDA was attempting to scrutinize the data in order to justify an EUA, then, this would have been extremely risky and stupid and negative "risking" his integrity and credibility, for Nader to have made the above statements.
Conclusion:
It's probable he does know that we did meet the PE with p value <0.05
Less Likely is that Nader has not seen the data & took big risk with big statements.
(9)
(0)Scroll down for more posts ▼
